Adicet Bio, Inc. financial data

Symbol
ACET on Nasdaq
Industry
Pharmaceutical Preparations
Location
131 Dartmouth Street, 3 Rd Floor, Boston, MA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
resTORbio, Inc. (to 8/21/2020)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.11K % -17.1%
Debt-to-equity 16.7 % +22.6%
Return On Equity -64 % -54.8%
Return On Assets -54.8 % -50.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.4M shares +91.3%
Common Stock, Shares, Outstanding 82.4M shares +91.3%
Entity Public Float 76.7M USD -82.1%
Common Stock, Value, Issued 8K USD +100%
Weighted Average Number of Shares Outstanding, Basic 90.6M shares +111%
Weighted Average Number of Shares Outstanding, Diluted 90.6M shares +111%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 101M USD +4.16%
General and Administrative Expense 27.4M USD +5%
Operating Income (Loss) -148M USD -20.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -137M USD -19.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -137M USD -19.2%
Earnings Per Share, Basic -2.52 USD/shares +7.69%
Earnings Per Share, Diluted -2.52 USD/shares +7.01%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 224M USD +9.06%
Other Assets, Current 409K USD -16.4%
Assets, Current 228M USD +9.44%
Property, Plant and Equipment, Net 24M USD -18.7%
Operating Lease, Right-of-Use Asset 15.9M USD -16.3%
Goodwill 0 USD -100%
Other Assets, Noncurrent 593K USD -41%
Assets 269M USD -3.17%
Accounts Payable, Current 1.9M USD -39.2%
Employee-related Liabilities, Current 4.71M USD +17.4%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 17.9M USD -4.96%
Operating Lease, Liability, Noncurrent 15.7M USD -19.9%
Other Liabilities, Noncurrent 116K USD -10.8%
Liabilities 33.7M USD -12.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -439M USD -45.6%
Stockholders' Equity Attributable to Parent 235M USD -1.65%
Liabilities and Equity 269M USD -3.17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.8M USD +5.17%
Net Cash Provided by (Used in) Financing Activities 111M USD
Net Cash Provided by (Used in) Investing Activities -239K USD +87.5%
Common Stock, Shares Authorized 300M shares +100%
Common Stock, Shares, Issued 82.4M shares +91.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 87.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 224M USD +9.06%
Deferred Tax Assets, Valuation Allowance 99.1M USD +10.7%
Deferred Tax Assets, Gross 103M USD +8.24%
Operating Lease, Liability 19.1M USD -15.5%
Payments to Acquire Property, Plant, and Equipment 239K USD -87.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -69.8M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid 23.3M USD
Property, Plant and Equipment, Gross 42.1M USD +2.55%
Operating Lease, Liability, Current 3.42M USD +12.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.16M USD -24.7%
Deferred Tax Assets, Operating Loss Carryforwards 65.6M USD -4.23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 18.5M USD +89.2%
Operating Lease, Payments 1.5M USD -31.8%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 4.66M USD +4.76%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 5.02M USD +16%
Deferred Tax Assets, Net of Valuation Allowance 3.68M USD -32.4%
Share-based Payment Arrangement, Expense 22.2M USD +21.5%
Operating Leases, Future Minimum Payments, Due in Three Years 4.01M USD -2.12%
Operating Leases, Future Minimum Payments Due 27M USD -2.15%
Interest Expense 4K USD -94%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%